Bisphenol	O
A	O
Induces	O
Sox2	O
in	O
ER	O
+	O
Breast	O
Cancer	O
Stem	O
-	O
Like	O
Cells	O
.	O


Bisphenol	O
A	O
(	O
BPA	O
)	O
is	O
an	O
endocrine	O
disrupting	O
compound	O
used	O
in	O
food	O
and	O
beverage	O
plastic	O
containers	O
and	O
has	O
been	O
shown	O
to	O
increase	O
breast	O
cancer	O
cellular	O
proliferation	O
.	O


However	O
,	O
the	O
concentrations	O
of	O
BPA	O
used	O
in	O
these	O
experiments	O
are	O
far	O
higher	O
than	O
the	O
physiological	O
levels	O
of	O
BPA	O
detected	O
in	O
the	O
human	O
body	O
.	O


We	O
observed	O
in	O
vitro	O
that	O
exposure	O
of	O
MCF	O
-	O
7	O
cells	O
to	O
physiological	O
concentrations	O
of	O
BPA	O
failed	O
to	O
increase	O
cell	O
proliferation	O
or	O
to	O
induce	O
canonical	O
estrogen	O
-	O
responsive	O
genes	O
(	O
pS2	O
and	O
progesterone	O
receptor	O
(	O
PR	O
)	O
)	O
,	O
in	O
contrast	O
to	O
17beta	O
-	O
estradiol	O
(	O
E2	O
)	O
treatment	O
.	O


However	O
,	O
MCF	O
-	O
7	O
cells	O
treated	O
with	O
10	O
nM	O
BPA	O
induced	O
ALDH1	O
expression	O
,	O
a	O
marker	O
of	O
human	O
mammary	O
stem	O
cells	O
.	O


When	O
treated	O
with	O
10	O
nM	O
BPA	O
,	O
mammospheres	O
derived	O
either	O
from	O
MCF	O
-	O
7	O
cells	O
,	O
a	O
patient	O
-	O
derived	O
xenograft	O
,	O
or	O
the	O
normal	O
mouse	O
mammary	O
gland	O
exhibited	O
increased	O
size	O
;	O
however	O
,	O
these	O
effects	O
were	O
not	O
observed	O
in	O
MDA	O
-	O
MB	O
-	O
231	O
mammospheres	O
.	O


Mechanistically	O
,	O
BPA	O
induced	O
SOX2	O
mRNA	O
and	O
protein	O
in	O
MCF	O
-	O
7	O
mammospheres	O
,	O
resulting	O
from	O
enhanced	O
CREB	O
phosphorylation	O
,	O
and	O
subsequent	O
binding	O
of	O
pCREB	O
to	O
a	O
SOX2	B-ENHANCER
downstream	I-ENHANCER
enhancer	E-ENHANCER
.	O


These	O
findings	O
suggest	O
that	O
physiological	O
levels	O
of	O
BPA	O
increase	O
estrogen	O
receptor	O
-	O
positive	O
breast	O
cancer	O
tumor	O
maintenance	O
through	O
enhanced	O
cancer	O
stem	O
-	O
like	O
cell	O
activity	O
via	O
direct	O
regulation	O
of	O
SOX2	O
transcription	O
.	O
